Ocular Features in Neurosarcoidosis

Background/aims: To determine the type of ocular involvement in patients with neurosarcoidosis, and evaluate whether the type of eye involvement may help in the diagnosis of neurosarcoidosis. Methods: Retrospective, case history study. We reviewed the medical records of 46 patients who attended the sarcoidosis clinics at the Royal Brompton and Moorfields Eye Hospital over a 4-year period with a diagnosis of definite and probable neurosarcoidosis supported by laboratory investigations and exclusion of other causes for the neurological symptoms. Results: Cranial nerve involvement was the most common neurological manifestation in this series. Among the 27 patients with cranial neuropathy, lower motor neurone facial palsy was the most frequently seen in 19 patients (70.4%). Diplopia was seen in four patients (14.9%). In three patients, this was because of common oculomotor nerve paresis. Uveitis was the most common intraocular manifestation in patients with neurosarcoidosis. The majority of these patients (9, 64.3%) suffered from anterior uveitis, but in 35.7% of them the inflammatory process involved the posterior segment. Conclusions: We found a higher incidence of ocular manifestations, including intraocular inflammation in neurosarcoidosis compared to that in systemic sarcoidosis elsewhere. The most common ocular complication seen in our series was anterior uveitis; however there were no associated clinical features of the uveitis in these series that could contribute to the differential diagnosis between neurosarcoidosis and other autoimmune disorders with neuro-ophthalmic features such as multiple sclerosis. Patients with neurological symptoms and associated intraocular inflammation should have a routine work-up for sarcoidosis. Investigations should include MRI scan of the brain and orbits and lumbar puncture in selected cases. Tissue biopsy should be attempted when clinically accessible lesions are available i.e., conjunctiva or lacrimal gland.

[1]  陶仲为 Sarcoidosis , 2009 .

[2]  L. Labree,et al.  Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. , 2007, Ophthalmology.

[3]  Jean-Marc Constans,et al.  Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load , 2006, Journal of the Neurological Sciences.

[4]  B. Schlosshauer,et al.  Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. , 2005, Investigative ophthalmology & visual science.

[5]  R. Nussenblatt,et al.  Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome. , 2005, American journal of ophthalmology.

[6]  E. Hoitsma,et al.  Neurosarcoidosis: a clinical dilemma , 2004, The Lancet Neurology.

[7]  G. Jaffe,et al.  Demographic-related variations in posterior segment ocular sarcoidosis. , 2004, Ophthalmology.

[8]  L. Bielory,et al.  Sarcoidosis of the Anterior Visual Pathway: 24 New Cases , 2003, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[9]  John W VanMeter,et al.  Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT): Clinical Applications. , 2003, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[10]  R. Bakshi,et al.  Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis , 2002, Journal of the Neurological Sciences.

[11]  R. Schwartzman,et al.  CSF-ACE activity in probable CNS neurosarcoidosis. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[12]  P. Kaiser,et al.  Chest computerized tomography in the evaluation of uveitis in elderly women. , 2002, American journal of ophthalmology.

[13]  G. McLennan,et al.  Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[14]  M. Trojano,et al.  The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes , 2001, Neurological Sciences.

[15]  S. Lightman,et al.  Symptomatic intraocular inflammation in multiple sclerosis , 2000, Clinical & experimental ophthalmology.

[16]  G. Soubrane,et al.  Neuropathie optique sarcoïdosique , 1999 .

[17]  J. Dale,et al.  Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. , 1999, Mayo Clinic proceedings.

[18]  M. Recio,et al.  MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. , 1999, AJNR. American journal of neuroradiology.

[19]  M. Rovaris,et al.  Central nervous system sarcoidosis--diagnosis and management. , 1999, QJM : monthly journal of the Association of Physicians.

[20]  S. Orengo-Nania,et al.  Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri. , 1999, American journal of ophthalmology.

[21]  V. Biousse,et al.  Multiple sclerosis associated with uveitis in two large clinic-based series , 1999, Neurology.

[22]  W R Kinkel,et al.  High‐Resolution Fluorodeoxyglucose Positron Emission Tomography Shows Both Global and Regional Cerebral Hypometabolism in Multiple Sclerosis , 1998, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[23]  M. Meziane,et al.  Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. , 1998, American journal of ophthalmology.

[24]  M. Yamaguchi,et al.  Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? , 1997, Clinics in chest medicine.

[25]  S. Harding,et al.  Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. , 1996, Archives of ophthalmology.

[26]  B. Stern,et al.  Therapeutic considerations in patients with refractory neurosarcoidosis. , 1995, Archives of neurology.

[27]  N. Newman,et al.  Optic nerve enlargement and chronic visual loss. , 1994, Survey of ophthalmology.

[28]  M. Lv,et al.  Sarcoidosis and its ocular manifestations , 1994 .

[29]  Sharma Op,et al.  Role of magnetic resonance imaging in neurosarcoidosis. , 1993 .

[30]  A. Rothova,et al.  Fundus pathology in neurosarcoidosis , 1993, International Ophthalmology.

[31]  E. Tozman,et al.  Sarcoidosis: clinical manifestations, epidemiology, therapy, and pathophysiology , 1991, Current opinion in rheumatology.

[32]  D. Laplane,et al.  Neurosarcoidosis: Signs, Course and Treatment in 35 Confirmed Cases , 1990 .

[33]  R. Spaide,et al.  Conjunctival biopsy in the diagnosis of sarcoidosis. , 1990, The British journal of ophthalmology.

[34]  N. Milman,et al.  Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. , 1990, Sarcoidosis.

[35]  J. Goust,et al.  Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis , 1989, Neurology.

[36]  A. Rothova,et al.  Risk factors for ocular sarcoidosis , 1989, Documenta Ophthalmologica.

[37]  R. Mckendall,et al.  Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis. , 1989, Archives of neurology.

[38]  E. Huhti,et al.  Course and outcome of ocular sarcoidosis. , 1988, American journal of ophthalmology.

[39]  V. Oksanen New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis. , 1987, Sarcoidosis.

[40]  D. Jabs,et al.  Ocular involvement in chronic sarcoidosis. , 1986, American journal of ophthalmology.

[41]  B. Stern,et al.  Sarcoidosis and its neurological manifestations. , 1985, Archives of neurology.

[42]  F. Fyhrquist,et al.  CSF ANGIOTENSIN-CONVERTING ENZYME IN NEUROSARCOIDOSIS , 1985, The Lancet.

[43]  E. Spokes,et al.  CSF ANGIOTENSIN-CONVERTING ENZYME IN NEUROSARCOIDOSIS , 1985, The Lancet.

[44]  L. Caplan,et al.  Neuro‐ophthalmologic signs in the angiitic form of neurosarcoidosis , 1983, Neurology.

[45]  R. Christenson,et al.  Interpretation of cerebrospinal fluid protein assays in various neurologic diseases. , 1983, Clinical chemistry.

[46]  H. Manz Pathobiology of Neurosarcoidosis and Clinicopathologic Correlation , 1983, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[47]  J. Selhorst,et al.  Sarcoid optic neuropathy , 1982, Neurology.

[48]  M. Sanders,et al.  Fundus changes in histologically confirmed sarcoidosis. , 1981, The British journal of ophthalmology.

[49]  G. Klintworth,et al.  Sarcoidosis and its ophthalmic manifestations. , 1978, American journal of ophthalmology.

[50]  P. Delaney Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. , 1977, Annals of internal medicine.

[51]  Maddocks Ac Letter: Sterilisation of cardiac bioptome. , 1974 .

[52]  H. Herlinger,et al.  Letter: Immunoglobulin standards. , 1974 .

[53]  L. Siltzbach The Kveim test in sarcoidosis. A study of 750 patients. , 1961, JAMA.

[54]  E. Hoitsma,et al.  Neurological Manifestations of Sarcoidosis , 2005 .

[55]  K. Digre,et al.  Neuro-ophthalmic Complications of Sarcoidosis , 2000, Seminars in neurology.

[56]  A. Glacet-Bernard,et al.  [Sarcoid optic neuropathy]. , 1999, Journal francais d'ophtalmologie.

[57]  J. Leavitt,et al.  Cost-effectiveness in the diagnosis of sarcoidosis: The conjunctival biopsy , 1998, Eye.

[58]  L. Messner,et al.  Sarcoidosis and its ocular manifestations. , 1994, Journal of the American Optometric Association.

[59]  J. Kadakia,et al.  Role of magnetic resonance imaging in neurosarcoidosis. , 1993, Sarcoidosis.

[60]  L. A. K. Bastiaensen,et al.  Conjunctival sarcoidosis , 1985, Documenta Ophthalmologica.